Edgewell Personal Care Co. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>Edgewell Personal Care Co. has filed its Q2 2024 10-Q report, detailing financial performance and position as of March 31, 2024.</b>

AI Summary

EDGEWELL PERSONAL CARE Co (EPC) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Edgewell Personal Care Co. filed its quarterly report (10-Q) on May 8, 2024, for the period ending March 31, 2024. The filing covers the second quarter of fiscal year 2024. The company's fiscal year ends on September 30. The filing includes financial data for periods ending March 31, 2024, September 30, 2023, and March 31, 2023. Edgewell Personal Care Co. is classified under SIC code 2844 for Perfumes, Cosmetics & Other Toilet Preparations.

Why It Matters

For investors and stakeholders tracking EDGEWELL PERSONAL CARE Co, this filing contains several important signals. This 10-Q filing provides investors with the latest financial snapshot of Edgewell Personal Care Co., crucial for understanding its performance and making informed investment decisions. The detailed financial statements and disclosures within the 10-Q allow for a comparison of the company's current performance against previous periods and industry benchmarks.

Risk Assessment

Risk Level: low — EDGEWELL PERSONAL CARE Co shows low risk based on this filing. The filing is a standard quarterly report (10-Q) and does not contain any immediate red flags or significant deviations from typical reporting requirements.

Analyst Insight

Review the detailed financial statements and management's discussion and analysis within the 10-Q to assess Edgewell Personal Care Co.'s financial health and operational performance.

Key Numbers

• 2024-03-31 — Period End Date (Conformed period of report)
• 2024-05-08 — Filing Date (Filed as of date)
• 2024 — Fiscal Year (Second quarter of fiscal year 2024)
• 0930 — Fiscal Year End (Company's fiscal year end)

Key Players & Entities

• EDGEWELL PERSONAL CARE Co (company) — Filer name
• 2024-03-31 (date) — Conformed period of report
• 2024-05-08 (date) — Filed as of date
• 0001096752 (company) — Central Index Key
• 2844 (industry) — Standard Industrial Classification
• MO (location) — State of incorporation
• 0930 (date) — Fiscal year end
• 1934 Act (regulation) — SEC Act

FAQ

Industry Context

Edgewell Personal Care Co. operates in the consumer goods sector, specifically within the beauty and personal care market, which is characterized by brand loyalty, innovation, and competitive pricing.

Regulatory Implications

The company is subject to standard SEC regulations for public companies, including the requirement to file quarterly (10-Q) and annual (10-K) reports detailing financial performance and business operations.

What Investors Should Do

1. Analyze the financial statements (balance sheet, income statement, cash flow) for the quarter ended March 31, 2024.
2. Review the Management's Discussion and Analysis (MD&A) section for insights into the company's performance drivers and outlook.
3. Compare key financial metrics with prior periods (e.g., Q2 2023) and industry peers to identify trends and potential risks or opportunities.

Key Dates

• 2024-03-31: Period End Date — End of the reporting period for the 10-Q filing.
• 2024-05-08: Filing Date — Date the 10-Q report was officially filed with the SEC.

Year-Over-Year Comparison

This filing is a standard 10-Q report for the period ending March 31, 2024, providing updated financial information compared to previous filings.

Key Financial Figures

• $0.01 — ich registered Common Stock, par value $0.01 per share EPC New York Stock Exchange

Filing Documents

• epc-20240331.htm (10-Q) — 1361KB
• epc10q03312024ex311.htm (EX-31.1) — 10KB
• epc10q03312024ex312.htm (EX-31.2) — 10KB
• epc10q03312024ex321.htm (EX-32.1) — 4KB
• epc10q03312024ex322.htm (EX-32.2) — 4KB
• epc-20240331_g1.jpg (GRAPHIC) — 5KB
• 0001628280-24-021700.txt (&nbsp;) — 7209KB
• epc-20240331.xsd (EX-101.SCH) — 39KB
• epc-20240331_cal.xml (EX-101.CAL) — 73KB
• epc-20240331_def.xml (EX-101.DEF) — 230KB
• epc-20240331_lab.xml (EX-101.LAB) — 575KB
• epc-20240331_pre.xml (EX-101.PRE) — 422KB
• epc-20240331_htm.xml (XML) — 1130KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements Condensed Consolidated Statements of Earnings and Comprehensive Income for the three and six months ended March 31, 2024 and 2023 3 Condensed Consolidated Balance Sheets as of March 31, 2024 and September 30, 2023 4 Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2024 and 2023 5 Condensed Consolidated Statements of Changes in Shareholders' Equity for the three and six months ended March 31, 2024 and 2023 6 Notes to Condensed Consolidated Financial Statements 8

Management's Discussion and Analysis of Financial Condition and Results of Operations 22

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 22

Quantitative and Qualitative Disclosures About Market Risk 34

Item 3. Quantitative and Qualitative Disclosures About Market Risk 34

Controls and Procedures 35

Item 4. Controls and Procedures 35

OTHER INFORMATION

PART II. OTHER INFORMATION

Unregistered Sales of Equity Securities and Use of Proceeds 36

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 36

Other Information 36

Item 5. Other Information 36

Exhibits 37

Item 6. Exhibits 37 SIGNATURE 38 2

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME (unaudited, in millions, except per share data) Three Months Ended March 31, Six Months Ended March 31, 2024 2023 2024 2023 Net sales $ 599.4 $ 598.4 $ 1,088.3 $ 1,067.5 Cost of products sold 341.3 356.1 632.5 635.6 Gross profit 258.1 242.3 455.8 431.9 Selling, general and administrative expense 107.5 105.2 210.8 200.9 Advertising and sales promotion expense 63.1 62.9 111.3 108.8 Research and development expense 14.2 14.4 27.5 27.8 Restructuring charges 3.2 3.0 10.0 5.7 Operating income 70.1 56.8 96.2 88.7 Interest expense associated with debt 20.4 20.7 40.2 40.6 Other expense, net 2.7 9.5 3.0 4.5 Earnings before income taxes 47.0 26.6 53.0 43.6 Income tax provision 11.0 7.2 12.2 11.8 Net earnings $ 36.0 $ 19.4 $ 40.8 $ 31.8 Earnings per share: Basic net earnings per share $ 0.72 $ 0.38 $ 0.82 $ 0.62 Diluted net earnings per share $ 0.72 $ 0.37 $ 0.81 $ 0.61 Net earnings $ 36.0 $ 19.4 $ 40.8 $ 31.8 Other comprehensive (loss) income, net of tax Foreign currency translation adjustments ( 16.0 ) 12.1 11.0 60.1 Pension and postretirement activity, net of tax (benefit) of $( 0.2 ), $ 1.6 , $( 0.8 ) and $ 1.5 ( 0.5 ) 4.5 ( 0.6 ) 4.3 Deferred loss on hedging activity, net of tax (benefit) of $ 1.3 , $ 0.1 , $( 0.3 ) and $( 3.7 ) 2.7 0.2 ( 0.7 ) ( 8.0 ) Total other comprehensive (loss) income, net of tax ( 13.8 ) 16.8 9.7 56.4 Total comprehensive income $ 22.2 $ 36.2 $ 50.5 $ 88.2 See accompanying Notes to Condensed Consolidated Financial Statements. 3 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited, in millions, except share data) March 31, 2024 September 30, 2023 Assets Current assets Cash and cash equivalents $ 196.2 $ 216.4 Trade receivables, less allowance for doubtful accounts of $ 5.9 and $ 5.6 130.6 106.2 Inventories 49

View Full Filing

View this 10-Q filing on SEC EDGAR